JOHNSON & JOHNSON

Trading Ideas Johnson & Johnson NEO Exchange

Equities

JNJ

CA47817E1034

End-of-day quote NEO Exchange Other stock markets 03:30:00 26/06/2024 am IST			5-day change	1st Jan Change
19.68 ^CAD	-0.25%		-0.05%	-6.95%

24/06	US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit	RE
24/06	J&J: 50M pupils helped through 'Sight for Kids' program	CF

Trading Ideas

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JOHNSON & JOHNSON :An end to the technical rebound lies ahead	27/19/27
JOHNSON & JOHNSON :The underlying trend is to the upside	12/17/12
JOHNSON & JOHNSON :Expect the comeback of a strong trend	10/17/10
JOHNSON & JOHNSON :Buying pressure	22/16/22
JOHNSON & JOHNSON :A good level to buy	12/16/12
JOHNSON & JOHNSON :Towards historic highs	26/12/26
JOHNSON & JOHNSON :Beginning of a bearish movement	26/12/26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 11:00 pm IST

Protect and grow your investments with the help of our experts

Securing my Investments

fermer